img

Global Viral Vector Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Viral Vector Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.
Viral Vector Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Viral Vector Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Viral Vector Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Viral Vector Vaccines key manufacturers include Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio, Creative Biogene, GE Healthcare, Pfizer and Sanofi, etc. Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio are top 3 players and held % sales share in total in 2022.
Viral Vector Vaccines can be divided into Adenovirus, Fowlpox Virus, Attenuated Yellow Fever and Vaccinia Virus Vectors, etc. Adenovirus is the mainstream product in the market, accounting for % sales share globally in 2022.
Viral Vector Vaccines is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Viral Vector Vaccines industry development. In 2022, global % sales of Viral Vector Vaccines went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Viral Vector Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Advanced Bioscience Laboratories
Boehringer Ingelheim
Brammer Bio
Creative Biogene
GE Healthcare
Pfizer
Sanofi
Segment by Type
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others

Segment by Application


Hospitals
Clinics
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Viral Vector Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Viral Vector Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Viral Vector Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Viral Vector Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Viral Vector Vaccines introduction, etc. Viral Vector Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Viral Vector Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Viral Vector Vaccines Market Overview
1.1 Viral Vector Vaccines Product Overview
1.2 Viral Vector Vaccines Market Segment by Type
1.2.1 Adenovirus
1.2.2 Fowlpox Virus
1.2.3 Attenuated Yellow Fever
1.2.4 Vaccinia Virus Vectors
1.2.5 Others
1.3 Global Viral Vector Vaccines Market Size by Type
1.3.1 Global Viral Vector Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Viral Vector Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Viral Vector Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Viral Vector Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Viral Vector Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Viral Vector Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Viral Vector Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Viral Vector Vaccines Sales Breakdown by Type (2018-2024)
2 Global Viral Vector Vaccines Market Competition by Company
2.1 Global Top Players by Viral Vector Vaccines Sales (2018-2024)
2.2 Global Top Players by Viral Vector Vaccines Revenue (2018-2024)
2.3 Global Top Players by Viral Vector Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Viral Vector Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Viral Vector Vaccines Market Competitive Situation and Trends
2.5.1 Viral Vector Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Viral Vector Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vector Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Viral Vector Vaccines Market
2.8 Key Manufacturers Viral Vector Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Viral Vector Vaccines Status and Outlook by Region
3.1 Global Viral Vector Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Viral Vector Vaccines Historic Market Size by Region
3.2.1 Global Viral Vector Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Viral Vector Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Viral Vector Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Viral Vector Vaccines Forecasted Market Size by Region
3.3.1 Global Viral Vector Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Viral Vector Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Viral Vector Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Viral Vector Vaccines by Application
4.1 Viral Vector Vaccines Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Viral Vector Vaccines Market Size by Application
4.2.1 Global Viral Vector Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Viral Vector Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Viral Vector Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Viral Vector Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Viral Vector Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Viral Vector Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Viral Vector Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Viral Vector Vaccines Sales Breakdown by Application (2018-2024)
5 North America Viral Vector Vaccines by Country
5.1 North America Viral Vector Vaccines Historic Market Size by Country
5.1.1 North America Viral Vector Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Viral Vector Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Viral Vector Vaccines Sales in Value by Country (2018-2024)
5.2 North America Viral Vector Vaccines Forecasted Market Size by Country
5.2.1 North America Viral Vector Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Viral Vector Vaccines Sales in Value by Country (2024-2034)
6 Europe Viral Vector Vaccines by Country
6.1 Europe Viral Vector Vaccines Historic Market Size by Country
6.1.1 Europe Viral Vector Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Viral Vector Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Viral Vector Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Viral Vector Vaccines Forecasted Market Size by Country
6.2.1 Europe Viral Vector Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Viral Vector Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Viral Vector Vaccines by Region
7.1 Asia-Pacific Viral Vector Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Viral Vector Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Viral Vector Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Viral Vector Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Viral Vector Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Viral Vector Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Viral Vector Vaccines Sales in Value by Region (2024-2034)
8 Latin America Viral Vector Vaccines by Country
8.1 Latin America Viral Vector Vaccines Historic Market Size by Country
8.1.1 Latin America Viral Vector Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Viral Vector Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Viral Vector Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Viral Vector Vaccines Forecasted Market Size by Country
8.2.1 Latin America Viral Vector Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Viral Vector Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Viral Vector Vaccines by Country
9.1 Middle East and Africa Viral Vector Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Viral Vector Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Viral Vector Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Viral Vector Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Viral Vector Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Viral Vector Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Viral Vector Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Advanced Bioscience Laboratories
10.1.1 Advanced Bioscience Laboratories Company Information
10.1.2 Advanced Bioscience Laboratories Introduction and Business Overview
10.1.3 Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Advanced Bioscience Laboratories Viral Vector Vaccines Products Offered
10.1.5 Advanced Bioscience Laboratories Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim Viral Vector Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Brammer Bio
10.3.1 Brammer Bio Company Information
10.3.2 Brammer Bio Introduction and Business Overview
10.3.3 Brammer Bio Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Brammer Bio Viral Vector Vaccines Products Offered
10.3.5 Brammer Bio Recent Development
10.4 Creative Biogene
10.4.1 Creative Biogene Company Information
10.4.2 Creative Biogene Introduction and Business Overview
10.4.3 Creative Biogene Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Creative Biogene Viral Vector Vaccines Products Offered
10.4.5 Creative Biogene Recent Development
10.5 GE Healthcare
10.5.1 GE Healthcare Company Information
10.5.2 GE Healthcare Introduction and Business Overview
10.5.3 GE Healthcare Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GE Healthcare Viral Vector Vaccines Products Offered
10.5.5 GE Healthcare Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pfizer Viral Vector Vaccines Products Offered
10.6.5 Pfizer Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Viral Vector Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Viral Vector Vaccines Products Offered
10.7.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Viral Vector Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Viral Vector Vaccines Industrial Chain Analysis
11.4 Viral Vector Vaccines Market Dynamics
11.4.1 Viral Vector Vaccines Industry Trends
11.4.2 Viral Vector Vaccines Market Drivers
11.4.3 Viral Vector Vaccines Market Challenges
11.4.4 Viral Vector Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Viral Vector Vaccines Distributors
12.3 Viral Vector Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Adenovirus
Table 2. Major Company of Fowlpox Virus
Table 3. Major Company of Attenuated Yellow Fever
Table 4. Major Company of Vaccinia Virus Vectors
Table 5. Major Company of Others
Table 6. Global Viral Vector Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Viral Vector Vaccines Sales by Type (2018-2024) & (K Units)
Table 8. Global Viral Vector Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Viral Vector Vaccines Sales by Type (2018-2024) & (US& Million)
Table 10. Global Viral Vector Vaccines Market Share in Value by Type (2018-2024)
Table 11. Global Viral Vector Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Viral Vector Vaccines Sales by Type (2024-2034) & (K Units)
Table 13. Global Viral Vector Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Viral Vector Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Viral Vector Vaccines Sales Market Share in Value by Type (2024-2034)
Table 16. Global Viral Vector Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Viral Vector Vaccines Sales by Type (2018-2024) & (K Units)
Table 18. North America Viral Vector Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Viral Vector Vaccines Sales (K Units) by Type (2018-2024)
Table 20. Europe Viral Vector Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Viral Vector Vaccines Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Viral Vector Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Viral Vector Vaccines Sales (K Units) by Type (2018-2024)
Table 24. Latin America Viral Vector Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Viral Vector Vaccines Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Viral Vector Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Viral Vector Vaccines Sales by Company (2018-2024) & (K Units)
Table 28. Global Viral Vector Vaccines Sales Share by Company (2018-2024)
Table 29. Global Viral Vector Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Viral Vector Vaccines Revenue Share by Company (2018-2024)
Table 31. Global Market Viral Vector Vaccines Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Viral Vector Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Viral Vector Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vector Vaccines as of 2022)
Table 35. Date of Key Manufacturers Enter into Viral Vector Vaccines Market
Table 36. Key Manufacturers Viral Vector Vaccines Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Viral Vector Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Viral Vector Vaccines Sales by Region (2018-2024) & (K Units)
Table 40. Global Viral Vector Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Viral Vector Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Viral Vector Vaccines Sales Market Share in Value by Region (2018-2024)
Table 43. Global Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Viral Vector Vaccines Sales by Region (2024-2034) & (K Units)
Table 45. Global Viral Vector Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Viral Vector Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Viral Vector Vaccines Sales Market Share in Value by Region (2024-2034)
Table 48. Global Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Viral Vector Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Viral Vector Vaccines Sales by Application (2018-2024) & (K Units)
Table 51. Global Viral Vector Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Viral Vector Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Viral Vector Vaccines Sales Market Share in Value by Application (2018-2024)
Table 54. Global Viral Vector Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Viral Vector Vaccines Sales by Application (2024-2034) & (K Units)
Table 56. Global Viral Vector Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Viral Vector Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Viral Vector Vaccines Sales Market Share in Value by Application (2024-2034)
Table 59. Global Viral Vector Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Viral Vector Vaccines Sales by Application (2018-2024) (K Units)
Table 61. North America Viral Vector Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Viral Vector Vaccines Sales by Application (2018-2024) (K Units)
Table 63. Europe Viral Vector Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Viral Vector Vaccines Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Viral Vector Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Viral Vector Vaccines Sales by Application (2018-2024) (K Units)
Table 67. Latin America Viral Vector Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Viral Vector Vaccines Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Viral Vector Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Viral Vector Vaccines Sales by Country (2018-2024) & (K Units)
Table 71. North America Viral Vector Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Viral Vector Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Viral Vector Vaccines Sales Market Share in Value by Country (2018-2024)
Table 74. North America Viral Vector Vaccines Sales by Country (2024-2034) & (K Units)
Table 75. North America Viral Vector Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Viral Vector Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Viral Vector Vaccines Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Viral Vector Vaccines Sales by Country (2018-2024) & (K Units)
Table 79. Europe Viral Vector Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Viral Vector Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Viral Vector Vaccines Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Viral Vector Vaccines Sales by Country (2024-2034) & (K Units)
Table 83. Europe Viral Vector Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Viral Vector Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Viral Vector Vaccines Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Viral Vector Vaccines Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Viral Vector Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Viral Vector Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Viral Vector Vaccines Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Viral Vector Vaccines Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Viral Vector Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Viral Vector Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Viral Vector Vaccines Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Viral Vector Vaccines Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Viral Vector Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Viral Vector Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Viral Vector Vaccines Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Viral Vector Vaccines Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Viral Vector Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Viral Vector Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Viral Vector Vaccines Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Viral Vector Vaccines Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Viral Vector Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Viral Vector Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Viral Vector Vaccines Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Viral Vector Vaccines Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Viral Vector Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Viral Vector Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Viral Vector Vaccines Sales Market Share in Value by Country (2024-2034)
Table 110. Advanced Bioscience Laboratories Company Information
Table 111. Advanced Bioscience Laboratories Introduction and Business Overview
Table 112. Advanced Bioscience Laboratories Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Advanced Bioscience Laboratories Viral Vector Vaccines Product
Table 114. Advanced Bioscience Laboratories Recent Development
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Introduction and Business Overview
Table 117. Boehringer Ingelheim Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Boehringer Ingelheim Viral Vector Vaccines Product
Table 119. Boehringer Ingelheim Recent Development
Table 120. Brammer Bio Company Information
Table 121. Brammer Bio Introduction and Business Overview
Table 122. Brammer Bio Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Brammer Bio Viral Vector Vaccines Product
Table 124. Brammer Bio Recent Development
Table 125. Creative Biogene Company Information
Table 126. Creative Biogene Introduction and Business Overview
Table 127. Creative Biogene Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Creative Biogene Viral Vector Vaccines Product
Table 129. Creative Biogene Recent Development
Table 130. GE Healthcare Company Information
Table 131. GE Healthcare Introduction and Business Overview
Table 132. GE Healthcare Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. GE Healthcare Viral Vector Vaccines Product
Table 134. GE Healthcare Recent Development
Table 135. Pfizer Company Information
Table 136. Pfizer Introduction and Business Overview
Table 137. Pfizer Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Pfizer Viral Vector Vaccines Product
Table 139. Pfizer Recent Development
Table 140. Sanofi Company Information
Table 141. Sanofi Introduction and Business Overview
Table 142. Sanofi Viral Vector Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Sanofi Viral Vector Vaccines Product
Table 144. Sanofi Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Viral Vector Vaccines Market Trends
Table 148. Viral Vector Vaccines Market Drivers
Table 149. Viral Vector Vaccines Market Challenges
Table 150. Viral Vector Vaccines Market Restraints
Table 151. Viral Vector Vaccines Distributors List
Table 152. Viral Vector Vaccines Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vector Vaccines Product Picture
Figure 2. Global Viral Vector Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Viral Vector Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Viral Vector Vaccines Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Adenovirus
Figure 6. Global Adenovirus Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Fowlpox Virus
Figure 8. Global Fowlpox Virus Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Attenuated Yellow Fever
Figure 10. Global Attenuated Yellow Fever Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Vaccinia Virus Vectors
Figure 12. Global Vaccinia Virus Vectors Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Viral Vector Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Viral Vector Vaccines Sales Market Share by Type in 2022 & 2034
Figure 17. North America Viral Vector Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. North America Viral Vector Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Europe Viral Vector Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Europe Viral Vector Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Viral Vector Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Viral Vector Vaccines Sales Market Share in Value by Type in 2022
Figure 23. Latin America Viral Vector Vaccines Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Viral Vector Vaccines Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Viral Vector Vaccines Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Viral Vector Vaccines Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Vector Vaccines Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Vector Vaccines Revenue in 2022
Figure 29. Viral Vector Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospitals
Figure 31. Global Hospitals Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Clinics
Figure 33. Global Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Viral Vector Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Viral Vector Vaccines Sales Market Share by Application in 2022 & 2034
Figure 38. North America Viral Vector Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. North America Viral Vector Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Europe Viral Vector Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Europe Viral Vector Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Viral Vector Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Viral Vector Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Latin America Viral Vector Vaccines Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Viral Vector Vaccines Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Viral Vector Vaccines Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Viral Vector Vaccines Manufacturing Cost Structure
Figure 49. Viral Vector Vaccines Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries